Company Filing History:
2 out of 190 
1 out of 147 
1 out of 418 
Years Active: 2000-2025
Title: Fumihiro Higashino: Innovator in Cancer Research
Introduction
Fumihiro Higashino is a prominent inventor based in Sapporo, Japan. He has made significant contributions to the field of cancer research, particularly through his innovative work on modified adenoviruses. With a total of 4 patents to his name, Higashino's inventions aim to enhance the safety and efficacy of cancer treatments.
Latest Patents
One of Higashino's latest patents focuses on a modified adenovirus designed to exhibit cytocidal activity on target cells while ensuring high safety. The invention includes a modified adenovirus that comprises an E1A gene, an enhancer sequence to boost the expression of the E1A gene, and an AU-rich element introduced into the 3′-untranslated region of a viral gene. This invention is crucial for the self-propagation of the virus. Additionally, it addresses cancer control by clarifying the relationship between the functions of the E1AF gene and the invasion and metastasis of cancers. This work has significant implications for controlling cancer cell invasion and improving detection and diagnosis methods.
Career Highlights
Higashino has worked with notable companies in the biotechnology sector, including Takara Shuzo Co., Inc. and Takara Bio Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in cancer research.
Collaborations
Throughout his career, Higashino has collaborated with esteemed colleagues such as Kei Fujinaga and Koichi Yoshida. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Fumihiro Higashino's work in the field of cancer research exemplifies the impact of innovative thinking on medical science. His contributions through modified adenoviruses and cancer control strategies highlight the importance of research and collaboration in advancing healthcare solutions.